Specific infiltration of langerin-positive dendritic cells in EBV-infected tonsil, Hodgkin lymphoma and nasopharyngeal carcinoma

International Journal of Cancer

Volumn 128, Issue 10, 2011, Pages 2501-2508

  Braz Silva, Paulo Henrique ^a,b   Vitale, Sébastien ^a   Butori, Catherine ^a,c   Guevara, Nicolas ^a,c   Santini, José ^c   Magalhães, Marina ^b   Hofman, Paul ^a,c   Doglio, Alain ^a,c  

^a INSERM   (France)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

dendritic cell infiltration; EBV immune response; EBV infection; EBV associated tumors; langerin CD207

Indexed keywords

CHEMOKINE RECEPTOR CCR6; LANGERIN; T6 ANTIGEN;

ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; EPSTEIN BARR VIRUS INFECTION; FLOW CYTOMETRY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LANGERHANS CELL; LYMPHOCYTE SUBPOPULATION; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANTIGENS, CD; BASE SEQUENCE; DENDRITIC CELLS; DNA PRIMERS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IN SITU HYBRIDIZATION; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; NASOPHARYNGEAL NEOPLASMS; PALATINE TONSIL;

EID: 79953175635     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25597     Document Type: Article

References (18)

1. Hislop AD, Taylor GS, Sauce D, Rickinson AB,. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 2007; 25: 587-617. (Pubitemid 46697918)
2. Munz C, Moormann A,. Immune escape by Epstein-Barr virus associated malignancies. Semin Cancer Biol 2008; 18: 381-7.
3. Mutyambizi K, Berger CL, Edelson RL,. The balance between immunity and tolerance: the role of Langerhans cells. Cell Mol Life Sci 2009; 66: 831-40.
4. Bursch LS, Wang L, Igyarto B, Kissenpfennig A, Malissen B, Kaplan DH, Hogquist KA,. Identification of a novel population of Langerin+ dendritic cells. J Exp Med 2007; 204: 3147-56.
5. Poulin LF, Henri S, de Bovis B, Devilard E, Kissenpfennig A, Malissen B,. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 2007; 204: 3119-31.
6. Ginhoux F, Collin MP, Bogunovic M, Abel M, Leboeuf M, Helft J, Ochando J, Kissenpfennig A, Malissen B, Grisotto M, Snoeck H, Randolph G, et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 2007; 204: 3133-46.
7. Nagao K, Ginhoux F, Leitner WW, Motegi S, Bennett CL, Clausen BE, Merad M, Udey MC,. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci USA 2009; 106: 3312-17.
8. Brewig N, Kissenpfennig A, Malissen B, Veit A, Bickert T, Fleischer B, Mostbock S, Ritter U,. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J Immunol 2009; 182: 774-83.
9. Henri S, Poulin LF, Tamoutounour S, Ardouin L, Guilliams M, de Bovis B, Devilard E, Viret C, Azukizawa H, Kissenpfennig A, Malissen B,. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 2009; 207: 189-206.
10. Lones MA, Shintaku IP, Weiss LM, Thung SN, Nichols WS, Geller SA,. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus. Hum Pathol 1997; 28: 533-9. (Pubitemid 27213048)
11. Villablanca EJ, Mora JR,. A two-step model for Langerhans cell migration to skin-draining LN. Eur J Immunol 2008; 38: 2975-80.
12. Walling DM, Flaitz CM, Hosein FG, Montes-Walters M, Nichols CM,. Effect of Epstein-Barr virus replication on Langerhans cells in pathogenesis of oral hairy leukoplakia. J Infect Dis 2004; 189: 1656-63. (Pubitemid 38648294)
13. Sakata N, Toguchi N, Kimura M, Nakayama M, Kawa K, Takemura T,. Development of Langerhans cell histiocytosis associated with chronic active Epstein-Barr virus infection. Pediatr Blood Cancer 2008; 50: 924-7. (Pubitemid 351354825)
14. Jeziorski E, Senechal B, Molina TJ, Devez F, Leruez-Ville M, Morand P, Glorion C, Mansuy L, Gaudelus J, Debre M, Jaubert F, Seigneurin JM, et al. Herpes-virus infection in patients with Langerhans cell histiocytosis: a case-controlled sero-epidemiological study, and in situ analysis. PLoS One 2008; 3: e3262.
15. Baumforth KR, Birgersdotter A, Reynolds GM, Wei W, Kapatai G, Flavell JR, Kalk E, Piper K, Lee S, Machado L, Hadley K, Sundblad A, et al. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates up-regulation of CCL20 and the migration of regulatory T cells. Am J Pathol 2008; 173: 195-204. (Pubitemid 351947967)
16. Chang KP, Hao SP, Chang JH, Wu CC, Tsang NM, Lee YS, Hsu CL, Ueng SH, Liu SC, Liu YL, Wei PC, Liang Y, et al. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes. Clin Cancer Res 2008; 14: 6979-87.
17. Caberg JH, Hubert P, Herman L, Herfs M, Roncarati P, Boniver J, Delvenne P,. Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunol Immunother 2009; 58: 39-47.
18. Chikwava K, Jaffe R,. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. Pediatr Dev Pathol 2004; 7: 607-14.